Afișare rezultate
Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: Evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation |
1, 23, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 3, 5, 1 |
4 ”Nicolae Testemițanu” State University of Medicine and Pharmacy, |
Annals of the Rheumatic Diseases |
Nr. / 2018 / ISSN - /ISSNe 0003-4967 |
Disponibil online 8 May, 2018. Descarcări-0. Vizualizări-826 |
1-1 of 1